Singapore Clinical Trial: A multicentre, randomised, double-blind, parallel group, placebo-controlled trial to assess the effects of oral TRPC6 inhibitor BI 764198 taken over a 104 week treatment period in adult and adolescent participants with primary focal segmental glomerulosclerosis (pFSGS) or genetic FSGS related to TRPC6 gene variants

Singapore, Aug. 29 -- The Health Sciences Authority received information related to the study titled 'A multicentre, randomised, double-blind, parallel group, placebo-controlled trial to assess the ef... Read More

Singapore Clinical Trial: A Phase 2b/Phase 3, randomized, double-blind, placebo-controlled, multicenter study, to investigate the efficacy and safety of lunsekimig in adult participants with inadequately controlled chronic obstructive pulmonary disease (COPD) characterized by an eosinophilic phenotype

Singapore, Aug. 29 -- The Health Sciences Authority received information related to the study titled 'A Phase 2b/Phase 3, randomized, double-blind, placebo-controlled, multicenter study, to investigat... Read More

Singapore Clinical Trial: A Phase 1, Randomized, Placebo-Controlled, Single Ascending Dose-Escalation Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY4167586 in Participants with Obesity or Overweight who are Otherwise Healthy.

Singapore, Aug. 29 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Randomized, Placebo-Controlled, Single Ascending Dose-Escalation Study to Investigate t... Read More

Singapore Clinical Trial: A Phase 3, Randomized, Open-label, Multicenter Clinical Study to Evaluate the Safety and Efficacy of MK-1084, Cetuximab, and mFOLFOX6 versus mFOLFOX6 With or Without Bevacizumab as First-line Treatment of Participants With KRAS G12C-mutant, Locally Advanced Unresectable or Metastatic Colorectal Cancer (KANDLELIT-012)

Singapore, Aug. 29 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Open-label, Multicenter Clinical Study to Evaluate the Safety and Efficacy ... Read More

Sunteck Realty to convene AGM

Mumbai, Aug. 29 -- Sunteck Realty announced that the Annual General Meeting(AGM) of the company will be held on 24 September 2026. Published by HT Digital Content Services with permission from Capita... Read More

Yatharth Hospital & Trauma Care Serv. schedules AGM

Mumbai, Aug. 29 -- Yatharth Hospital & Trauma Care Serv. announced that the Annual General Meeting(AGM) of the company will be held on 25 September 2026. Published by HT Digital Content Services with... Read More

Aptech schedules AGM

Mumbai, Aug. 29 -- Aptech announced that the Annual General Meeting(AGM) of the company will be held on 23 September 2026. Published by HT Digital Content Services with permission from Capital Market... Read More

Amiable Logistics India to convene AGM

Mumbai, Aug. 29 -- Amiable Logistics India announced that the 24th Annual General Meeting(AGM) of the company will be held on 29 September 2026. Published by HT Digital Content Services with permissi... Read More

Mustafa Kamal offered himself accountable over deaths of 14 newborns at PIMSPublished on: August 29, 2026 10:03 AM

Pakistan, Aug. 29 -- Federal Health Minister Mustafa Kamal has offered himself for accountability over the deaths of 14 newborns at PIMS in Islamabad. He told the Senate that there was still no clear ... Read More

Gretex Industries announces board meeting date

Mumbai, Aug. 29 -- Gretex Industries will hold a meeting of the Board of Directors of the Company on 4 September 2026. Published by HT Digital Content Services with permission from Capital Market.... Read More

• «
• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• »
• »»